PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.49%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
13.22%
Positive gross profit growth while QRVO is negative. John Neff would see a clear operational edge over the competitor.
597.37%
EBIT growth 50-75% of QRVO's 810.08%. Martin Whitman would suspect suboptimal resource allocation.
634.21%
Operating income growth above 1.5x QRVO's 6.61%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
215.38%
Positive net income growth while QRVO is negative. John Neff might see a big relative performance advantage.
233.33%
Positive EPS growth while QRVO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
233.33%
Positive diluted EPS growth while QRVO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.46%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
3.22%
Dividend growth of 3.22% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
82.20%
Positive OCF growth while QRVO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
146.94%
Positive FCF growth while QRVO is negative. John Neff would see a strong competitive edge in net cash generation.
9.50%
10Y revenue/share CAGR under 50% of QRVO's 95.48%. Michael Burry would suspect a lasting competitive disadvantage.
-11.69%
Negative 5Y CAGR while QRVO stands at 27.97%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-40.47%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
100.19%
5Y OCF/share CAGR above 1.5x QRVO's 5.08%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
6.52%
Positive 3Y OCF/share CAGR while QRVO is negative. John Neff might see a big short-term edge in operational efficiency.
43.07%
Below 50% of QRVO's 1921.69%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1.45%
Positive 5Y CAGR while QRVO is negative. John Neff might view this as a strong mid-term relative advantage.
-45.24%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
137.33%
Positive 5Y equity/share CAGR while QRVO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
51.12%
Positive short-term equity growth while QRVO is negative. John Neff sees a strong advantage in near-term net worth buildup.
93.58%
Dividend/share CAGR of 93.58% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
33.51%
Stable or rising mid-term dividends while QRVO is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
2.52%
3Y dividend/share CAGR of 2.52% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.07%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-19.26%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.61%
Asset growth above 1.5x QRVO's 1.09%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.34%
Under 50% of QRVO's 3.14%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.15%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.90%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-31.95%
We cut SG&A while QRVO invests at 19.11%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.